ROS activates multiple transcription factors including AP-1, NF-κB, HIF-1α, p53, PPARγ, β-catenin/Wnt, and Nrf2, which in turn increase expression of growth factors and pro-inflammatory cytokines, leading to cell proliferation and increased risk of neoplasia [13]. This evidence concerns the gene NFE2L2 and neoplasm.